Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome
This study was designed to evaluate insulin resistance and plasma levels of visfatin and
resistin in obese and non-obese patients with polycystic ovary syndrome (PCOS). A total of
37 premenopausal PCOS patients with (n= 18, mean (SD) age: 27.5 (5.7 years) or without
obesity (n= 19, mean (SD) age: 23.7 (3.1) years) and healthy volunteers (n= 18, mean (SD)
age: 29.8 (4.1) years) were included in this study. Data on clinical characteristics, glycemic
parameters and lipid parameters were recorded for each subject as were plasma visfatin …
resistin in obese and non-obese patients with polycystic ovary syndrome (PCOS). A total of
37 premenopausal PCOS patients with (n= 18, mean (SD) age: 27.5 (5.7 years) or without
obesity (n= 19, mean (SD) age: 23.7 (3.1) years) and healthy volunteers (n= 18, mean (SD)
age: 29.8 (4.1) years) were included in this study. Data on clinical characteristics, glycemic
parameters and lipid parameters were recorded for each subject as were plasma visfatin …
Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome
S Cander, B Gül - 2015 - acikerisim.uludag.edu.tr
This study was designed to evaluate insulin resistance and plasma levels of visfatin and
resistin in obese and non-obese patients with polycystic ovary syndrome (PCOS). A total of
37 premenopausal PCOS patients with (n= 18, mean (SD) age: 27.5 (5.7 years) or without
obesity (n= 19, mean (SD) age: 23.7 (3.1) years) and healthy volunteers (n= 18, mean (SD)
age: 29.8 (4.1) years) were included in this study. Data on clinical characteristics, glycemic
parameters and lipid parameters were recorded for each subject as were plasma visfatin …
resistin in obese and non-obese patients with polycystic ovary syndrome (PCOS). A total of
37 premenopausal PCOS patients with (n= 18, mean (SD) age: 27.5 (5.7 years) or without
obesity (n= 19, mean (SD) age: 23.7 (3.1) years) and healthy volunteers (n= 18, mean (SD)
age: 29.8 (4.1) years) were included in this study. Data on clinical characteristics, glycemic
parameters and lipid parameters were recorded for each subject as were plasma visfatin …